These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 152491)

  • 1. Considerations in immunologic monitoring of long-term transplant recipients.
    Thomas J; Thomas F; Johns C; Lee HM
    Transplant Proc; 1978 Sep; 10(3):569-72. PubMed ID: 152491
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressor cells inhibiting the generation of cytotoxic T lymphocytes in long-term human transplant recipients.
    Thomas J; Johns C; Hoffmann S; Thomas F; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():87-9. PubMed ID: 158755
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term follow-up of renal transplant recipients using immunologic monitoring.
    Miller J; Kyriakides G; Flaa C
    Transplant Proc; 1979 Mar; 11(1):360-3. PubMed ID: 156425
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of T-cell-mediated cytotoxic allograft response in human transplant recipients.
    Thomas J; Thomas F; Edwards E; Hoffman S; Lee HM
    Transplant Proc; 1981 Sep; 13(3):1594-8. PubMed ID: 6458130
    [No Abstract]   [Full Text] [Related]  

  • 5. The correlation of kidney transplant survival with lymphocyte mediated cytotoxicity on B cell targets.
    Nathan P; Plessinger RT; First MR
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():62-7. PubMed ID: 386322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence of a specific defect in effector cell formation following kidney and liver allotransplants in humans].
    Wonigkeit K; Pichlmayr R
    Chir Forum Exp Klin Forsch; 1977 Apr; ():269-73. PubMed ID: 156112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for suppressor cells and reduced CML induction by the donor in transplant patients.
    Liburd EM; Pazderka V; Kovithavongs T; Dossetor JB
    Transplant Proc; 1978 Sep; 10(3):557-61. PubMed ID: 152490
    [No Abstract]   [Full Text] [Related]  

  • 8. Posttransplant monitoring of donor-specific T-cell reactivity at the precursor cell level.
    Wonigeit K; Pichlmayr R
    Transplant Proc; 1978 Sep; 10(3):563-7. PubMed ID: 362636
    [No Abstract]   [Full Text] [Related]  

  • 9. Donor-specific CML hyporesponsiveness after successful renal transplantation: studies on the mechanism.
    Thomas JM; Thomas FT; Hoffman S; Johns C; Mendez-Picon G; Lee HM
    Transplant Proc; 1979 Jun; 11(2):1258-9. PubMed ID: 157568
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression and stimulation of T cell clones of renal transplant recipients by autologous post-transplant sera: a role for regulatory antibodies.
    Daniel V; Opelz G
    Transplant Proc; 1987 Oct; 19(5):4210-3. PubMed ID: 2960049
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of T cell sensitization in renal transplant patients with mixed lymphocyte culture-cell-mediated lympholysis.
    Suranyi MG; Hall BM; Duggin GG; Horvath JS; Johnson JR; Sheil AG; Tiller DJ
    Transplant Proc; 1987 Apr; 19(2):2873-5. PubMed ID: 2951917
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period.
    Renna E; Sansonetti P; Nesci C; Famulari A; Cortesini R
    Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective monitoring and modulation of recipient immune reactivity to prevent rejection in early posttransplant period.
    Thomas F; Mendez-Picon G; Thomas J; Lee HM; Lower R
    Transplant Proc; 1978 Sep; 10(3):537-41. PubMed ID: 362632
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients.
    Fuller TC; Cosimi AB; Russell PS
    Transplant Proc; 1978 Jun; 10(2):463-6. PubMed ID: 354136
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of histocompatibility testing versus immunoreactive predisposition on kidney transplant survival.
    Kyriakides GK; Severyn W; Fuller L; Esquenazi V; Flaa C; Olson L; Miller J
    Surgery; 1982 Aug; 92(2):354-61. PubMed ID: 6213054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell flow-cytometry crossmatch and long-term renal graft survival.
    Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
    Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization.
    Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB
    Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465
    [No Abstract]   [Full Text] [Related]  

  • 19. Long time follow up of CD28- CD4+ T cells in living kidney transplant patients.
    Kato M; Ono Y; Kinukawa T; Hattori R; Kamihira O; Ohshima S
    Clin Transplant; 2004 Jun; 18(3):242-6. PubMed ID: 15142043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifactorial analysis of factors influencing graft survival in recipients of living related renal allografts.
    Green WF; Niblack GD; Johnson HK; Richie RE; Tallent MB; MacDonnell R; Turner B; Harbison P; Ganaway S
    Transplant Proc; 1982 Jun; 14(2):282-6. PubMed ID: 6214057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.